2014 Genitourinary Cancers Symposium San Francisco, CA, USA, 30 January-1 February 2014 The American Society of Clinical Oncology symposium dedicated to genitourinary tumors represents an unmissable opportunity for the whole oncology community with a special interest in the diagnosis and treatment of genitorurinary tract malignancies, in particular kidney and prostate tumors. The 2014 Genitourinary Cancers Symposium focused attention on the need to find a personalized therapy for metastatic renal cell carcinoma and castration-resistant prostate cancer patients. The development of biomarkers for tumor response and/or resistance will represent a major step in this context and has been the focus of several researches at the symposium.
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice / Bianconi M.; Santoni M.; Massari F.; Faloppi L.; Prete M.D.; Giampieri R.; Ciccarese C.; Modena A.; Tortora G.; Scartozzi M.; Cascinu S.. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - ELETTRONICO. - 10:14(2014), pp. 2103-2106. [10.2217/fon.14.185]
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice
Massari F.;
2014
Abstract
2014 Genitourinary Cancers Symposium San Francisco, CA, USA, 30 January-1 February 2014 The American Society of Clinical Oncology symposium dedicated to genitourinary tumors represents an unmissable opportunity for the whole oncology community with a special interest in the diagnosis and treatment of genitorurinary tract malignancies, in particular kidney and prostate tumors. The 2014 Genitourinary Cancers Symposium focused attention on the need to find a personalized therapy for metastatic renal cell carcinoma and castration-resistant prostate cancer patients. The development of biomarkers for tumor response and/or resistance will represent a major step in this context and has been the focus of several researches at the symposium.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
